Company intelligence / Profile preview

Medeon Biodesign

Ownership: Private
Development stage: Other

Overview

Medeon Biodesign has developed multiple innovative medical devices for minimally invasive procedures. Several products have received regulatory approval or are in late-stage clinical development. The company also operates as a CDMO for advanced medical devices, providing one-stop services to international customers.

Therapeutic areas: Men's HealthCardiovascularOther
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Collaborates with physicians and medtech companies globallyStrong emphasis on international licensing and partnerships with leading medtech firms

Beyond the preview

Go deeper on Medeon Biodesign.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medeon Biodesign.

Explore the full profile